These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3877181)

  • 1. Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.
    Holman BL; Gibson RE; Hill TC; Eckelman WC; Albert M; Reba RC
    JAMA; 1985 Dec; 254(21):3063-6. PubMed ID: 3877181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.
    Wyper DJ; Brown D; Patterson J; Owens J; Hunter R; Teasdale E; McCulloch J
    Eur J Nucl Med; 1993 May; 20(5):379-86. PubMed ID: 8519256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
    Drayer B; Jaszczak R; Coleman E; Storni A; Greer K; Petry N; Lischko M; Flanagan S
    J Comput Assist Tomogr; 1982 Jun; 6(3):536-43. PubMed ID: 6980235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral muscarinic receptors in primary degenerative dementia as evaluated by SPECT with iodine-123-labeled QNB.
    Weinberger DR; Mann U; Gibson RE; Coppola R; Jones DW; Braun AR; Berman KF; Sunderland T; Reba RC; Chase TN
    Adv Neurol; 1990; 51():147-50. PubMed ID: 2294653
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.
    Pakrasi S; Colloby SJ; Firbank MJ; Perry EK; Wyper DJ; Owens J; McKeith IG; Williams ED; O'Brien JT
    J Neurol; 2007 Jul; 254(7):907-13. PubMed ID: 17361343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.
    Weinberger DR; Gibson R; Coppola R; Jones DW; Molchan S; Sunderland T; Berman KF; Reba RC
    Arch Neurol; 1991 Feb; 48(2):169-76. PubMed ID: 1993008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
    Brown D; Chisholm JA; Owens J; Pimlott S; Patterson J; Wyper D
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):296-300. PubMed ID: 12552349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123.
    Johnson KA; Mueller ST; Walshe TM; English RJ; Holman BL
    Arch Neurol; 1987 Feb; 44(2):165-8. PubMed ID: 3492992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic evidence that (R)-3-quinuclidinyl (S)-4-fluoromethylbenzilate ((R,S)-FMeQNB) displays in vivo selectivity for the muscarinic m2 subtype.
    Boulay SF; Sood VK; Rayeq MR; Zeeberg BR; Eckelman WC
    Nucl Med Biol; 1996 Oct; 23(7):889-96. PubMed ID: 8971856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of cerebral muscarinic receptors with I-123 QNB and SPECT: studies in normal subjects and patients with dementia.
    Weinberger DR; Jones DW; Sunderland T; Lee KS; Sexton R; Gorey J; Reba R
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():194A-195A. PubMed ID: 1498808
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo imaging of muscarinic receptors in the aging female brain with (R,R)[123I]-I-QNB and single photon emission tomography.
    Norbury R; Travis MJ; Erlandsson K; Waddington W; Owens J; Pimlott S; Ell PJ; Murphy DG
    Exp Gerontol; 2005 Mar; 40(3):137-45. PubMed ID: 15763390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.
    Johnson KA; Holman BL; Mueller SP; Rosen TJ; English R; Nagel JS; Growdon JH
    Arch Neurol; 1988 Apr; 45(4):392-6. PubMed ID: 3258512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.
    Claus JJ; Dubois EA; Booij J; Habraken J; de Munck JC; van Herk M; Verbeeten B; van Royen EA
    Eur J Nucl Med; 1997 Jun; 24(6):602-8. PubMed ID: 9169565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain.
    Lee J; Paik CH; Kiesewetter DO; Park SG; Eckelman WC
    Nucl Med Biol; 1995 Aug; 22(6):773-81. PubMed ID: 8535338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
    Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
    Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer.
    Eckelman WC; Eng R; Rzeszotarski WJ; Gibson RE; Francis B; Reba RC
    J Nucl Med; 1985 Jun; 26(6):637-42. PubMed ID: 3998853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease.
    Nobuhara K; Halldin C; Hall H; Karlsson P; Farde L; Hiltunen J; McPherson DW; Savonen A; Bergström KA; Pauli S; Swahn CG; Larsson SA; Schnell PO; Sedvall G
    Psychopharmacology (Berl); 2000 Mar; 149(1):45-55. PubMed ID: 10789882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.
    Colloby SJ; Pakrasi S; Firbank MJ; Perry EK; Piggott MA; Owens J; Wyper DJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Neuroimage; 2006 Nov; 33(2):423-9. PubMed ID: 16959499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of dementia with single photon emission computed tomography.
    Jagust WJ; Budinger TF; Reed BR
    Arch Neurol; 1987 Mar; 44(3):258-62. PubMed ID: 3493756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.